Earl S Ford1, Wayne H Giles, Ali H Mokdad, Gary L Myers. 1. Division of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA. eford@cdc.gov
Abstract
BACKGROUND: Understanding the distribution of C-reactive protein (CRP) concentration among adult women in the US helps to establish the magnitude of women at increased risk for cardiovascular disease. METHODS: We examined the distribution and correlates of CRP, using data from 2205 women >or=20 years of age from the National Health and Nutrition Examination Survey 1999-2000. CRP was measured with a high-sensitivity latex-enhanced turbidimetric assay. RESULTS: CRP concentration ranged from 0.1 to 296.0 mg/L (median, 2.7 mg/L). After exclusion of women with a CRP concentration >10 mg/L, the median was 2.2 mg/L. Approximately 25.7% of women, representing approximately 26.8 million women, did not report using hormone replacement therapy and had a CRP concentration >3.0 to 10 mg/L, a category considered to indicate high risk for cardiovascular disease. Multiple linear regression analysis included age, race or ethnicity, education, smoking status, total cholesterol concentration, triglyceride concentration, systolic blood pressure, waist circumference, and concentrations of glucose, insulin, c-peptide, and glycated hemoglobin. CRP concentration varied by race or ethnicity (Mexican American > white) and hormone replacement therapy (users > nonusers). In addition, significant and independent associations existed between CRP and waist circumference, total cholesterol and triglyceride concentrations, and systolic blood pressure but not age, smoking status, alcohol use, insulin concentration, glycated hemoglobin, and c-peptide concentration. CONCLUSION: Large numbers of US women have an increased concentration of CRP.
BACKGROUND: Understanding the distribution of C-reactive protein (CRP) concentration among adult women in the US helps to establish the magnitude of women at increased risk for cardiovascular disease. METHODS: We examined the distribution and correlates of CRP, using data from 2205 women >or=20 years of age from the National Health and Nutrition Examination Survey 1999-2000. CRP was measured with a high-sensitivity latex-enhanced turbidimetric assay. RESULTS:CRP concentration ranged from 0.1 to 296.0 mg/L (median, 2.7 mg/L). After exclusion of women with a CRP concentration >10 mg/L, the median was 2.2 mg/L. Approximately 25.7% of women, representing approximately 26.8 million women, did not report using hormone replacement therapy and had a CRP concentration >3.0 to 10 mg/L, a category considered to indicate high risk for cardiovascular disease. Multiple linear regression analysis included age, race or ethnicity, education, smoking status, total cholesterol concentration, triglyceride concentration, systolic blood pressure, waist circumference, and concentrations of glucose, insulin, c-peptide, and glycated hemoglobin. CRP concentration varied by race or ethnicity (Mexican American > white) and hormone replacement therapy (users > nonusers). In addition, significant and independent associations existed between CRP and waist circumference, total cholesterol and triglyceride concentrations, and systolic blood pressure but not age, smoking status, alcohol use, insulin concentration, glycated hemoglobin, and c-peptide concentration. CONCLUSION: Large numbers of US women have an increased concentration of CRP.
Authors: Eileen M Crimmins; Jung Ki Kim; Dawn E Alley; Arun Karlamangla; Teresa Seeman Journal: Am J Public Health Date: 2007-05-30 Impact factor: 9.308
Authors: Sandi L Navarro; Elizabeth D Kantor; Xiaoling Song; Ginger L Milne; Johanna W Lampe; Mario Kratz; Emily White Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-01-11 Impact factor: 4.254
Authors: Amit Khera; Gloria L Vega; Sandeep R Das; Colby Ayers; Darren K McGuire; Scott M Grundy; James A de Lemos Journal: J Clin Endocrinol Metab Date: 2009-06-30 Impact factor: 5.958
Authors: Yi Zhai; Xiao Ming Shi; Simon Michael Fitzgerald; Han Zhu Qian; Virginia B Kraus; Melanie Sereny; Perry Hu; Zhao Xue Yin; Jian Wei Xu; Yi Zeng Journal: Biomed Environ Sci Date: 2012-06 Impact factor: 3.118
Authors: Christine L Rioux; Katherine L Tucker; Mkaya Mwamburi; David M Gute; Steven A Cohen; Doug Brugge Journal: Environ Health Perspect Date: 2010-02-02 Impact factor: 9.031
Authors: Aydin Nazmi; Isabel O Oliveira; Bernardo L Horta; Denise P Gigante; Cesar G Victora Journal: Soc Sci Med Date: 2010-02-04 Impact factor: 4.634